Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. [artículo]
Por: Gutiérrez Martínez, Eduardo [Nefrología]
| Gutiérrez Solís, Elena [Nefrología] | Huerta Arroyo, Ana María [Nefrología] | Gutiérrez Millet, Víctor [Nefrología] | Morales Ruiz, Enrique [Nefrología] | Praga Terente, Manuel [Nefrología].
Colaborador(es): Servicio de Nefrología | Instituto de Investigación imas12.
Editor: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013Descripción: 28(2):405-12.Recursos en línea: Solicitar documento Resumen: BACKGROUND: Several studies have demonstrated a short-term antiproteinuric effect of mineralocorticoid receptor blockers (MRB) on proteinuric kidney diseases, but no information is available about the long-term persistence (>1 year) of such reduction in proteinuria and the long-term effects of MRB on renal function.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC6828 (Navegar estantería) | Disponible |
Formato Vancouver:
Morales E, Millet VG, Rojas-Rivera J, Huerta A, Gutiérrez E, Gutiérrez-Solís E et al. Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. Nephrol Dial Transplant.
2013 Feb;28(2):405-12.
PMID: 23222416
Contiene 26 referencias
BACKGROUND: Several studies have demonstrated a short-term antiproteinuric effect of mineralocorticoid receptor blockers (MRB) on proteinuric kidney diseases, but no information is available about the long-term persistence (>1 year) of such reduction in proteinuria and the long-term effects of MRB on renal function.
No hay comentarios para este ejemplar.